🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

Recruitingn/aAges 18 Years - 70 YearsAllThe Searle Company Limited Pakistan
NCT06625346 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The American College of Cardiology/American Heart Association hypertension guidelines recommend treatment initiation with dual antihypertensive therapy in adults with stage 2 hypertension (corresponding to grade 1 and 2 in the ESH classification) and an average BP \>20/10 mm Hg above target. Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). In Pakistan multiple studies were conducted on Hypertension and use of Single Pill Combination in uncontrolled Hypertension. However, no study was conducted to assess the role of Single Pill Combination (SPC) like Amlodipine and Valsartan in newly diagnosed hypertension and to assess their quality of life by patients' satisfaction with their medication after managing the hypertension with the SPC.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient with a clinical history of Hypertension (systolic blood pressure greater than or equal to 140 mmHg or a diastolic blood pressure greater than or equal to 90 mmHg) and never had antihypertensive treatment. * Patient aged ≥18 and ≤70 years inclusive of either sex. * Patient with ability to understand and sign written informed consent form. Exclusion Criteria: * • Patients with already on antihypertensive treatment or secondary hypertension * Pregnant women or nursing mothers * Patients with acute illnesses or psychiatric diagnosis * Known hypersensitivity to Extor product, the metabolites, or formulation excipients. * Treated with Extor to evaluate safety as per approved prescribing information for Extor in Pakistan.
💊

What it tests

  • Fixed-Dose Combination of Amlodipine/Valsartan
📍

Where

2 sites
Kuwait Teaching Hospital
Peshawar, Pakistan
National Medical Centre
Karachi, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy